Literature DB >> 17284092

Treatment strategies after a single seizure : rationale for immediate versus deferred treatment.

Laura C Miller1, Frank W Drislane.   

Abstract

What is the rationale for the treatment of an epileptic seizure? More specifically, should a first seizure be treated as soon as it is diagnosed or should one defer treatment until a second seizure occurs? Several studies indicate that the risk of a second (unprovoked) seizure is <50%, but studies vary in methodology and most have reviewed outcome in children only. Also, many patients were maintained on antiepileptic drugs (AEDs) during these studies, meaning that the risk for seizure recurrence was perhaps underestimated compared with the risk if untreated. Most neurologists recommend waiting for a second seizure in order to avoid complications of medications that might prove to be unnecessary. Several large studies show that delaying treatment until a second seizure occurs does not worsen the course of epilepsy or likelihood of eventual seizure control. Seizures attributable to an acute illness ('acute symptomatic', provoked seizures) usually resolve with treatment of the underlying illness and thus long-term AEDs are often unwarranted. Nevertheless, seizures arising in certain circumstances are more likely to recur and there are special considerations for patients with strokes, tumours, infections and dementia, and also after head injury or neurosurgery. Patient preferences with regard to risk and benefit also enter into the decision on whether to initiate AED treatment after a single seizure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17284092     DOI: 10.2165/00023210-200721020-00001

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  64 in total

1.  Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.

Authors:  A Marson; A Jacoby; A Johnson; L Kim; C Gamble; D Chadwick
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

2.  Risk of recurrent seizures after two unprovoked seizures.

Authors:  W A Hauser; S S Rich; J R Lee; J F Annegers; V E Anderson
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

3.  Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects.

Authors:  B Pascual-Sedano; A Iranzo; J Marti-Fàbregas; P Domingo; A Escartin; M Fuster; J L Barrio; M A Sambeat
Journal:  Arch Neurol       Date:  1999-05

4.  Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project.

Authors:  J Burn; M Dennis; J Bamford; P Sandercock; D Wade; C Warlow
Journal:  BMJ       Date:  1997-12-13

5.  Prevalence and prognosis of epilepsy in patients with multiple sclerosis.

Authors:  E Kinnunen; J Wikström
Journal:  Epilepsia       Date:  1986 Nov-Dec       Impact factor: 5.864

6.  Phenytoin and postoperative epilepsy. A double-blind study.

Authors:  J B North; R K Penhall; A Hanieh; D B Frewin; W B Taylor
Journal:  J Neurosurg       Date:  1983-05       Impact factor: 5.115

7.  Epilepsy after stroke.

Authors:  T S Olsen; H Høgenhaven; O Thage
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

8.  Epileptic seizures in acute stroke.

Authors:  C J Kilpatrick; S M Davis; B M Tress; S C Rossiter; J L Hopper; M L Vandendriesen
Journal:  Arch Neurol       Date:  1990-02

9.  Risk factors for developing seizures after a stroke.

Authors:  M E Lancman; A Golimstok; J Norscini; R Granillo
Journal:  Epilepsia       Date:  1993 Jan-Feb       Impact factor: 5.864

Review 10.  Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  Bernard S Chang; Daniel H Lowenstein
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.